These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 117024)

  • 1. Bactericidal antibody response to Pseudomonas aeruginosa by adults with urinary tract infections.
    Smalley DL; Ourth DD
    J Clin Microbiol; 1979 Aug; 10(2):251-2. PubMed ID: 117024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological nonidentity of Pseudomonas paucimobilis with Pseudomonas aeruginosa and Pseudomonas cepacia.
    Smalley DL; Ourth DD
    J Clin Microbiol; 1980 Sep; 12(3):439-41. PubMed ID: 6783679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.
    Guttman RM; Waisbren BA
    Clin Exp Immunol; 1975 Jan; 19(1):121-30. PubMed ID: 54231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
    Zarubina EK; Svetukhin AM; Edvabnaia LS
    Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoserology of Pseudomonas aeruginosa infections in man. III. Site of infection, duration of the presence of Pseudomonas aeruginosa and antibody response.
    Petrás G; Adám M; Lányi B; Konkoly Thege M; Szentmihályi A
    Acta Microbiol Hung; 1984; 31(2):109-16. PubMed ID: 6464657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection.
    Khawaldeh A; Morales S; Dillon B; Alavidze Z; Ginn AN; Thomas L; Chapman SJ; Dublanchet A; Smithyman A; Iredell JR
    J Med Microbiol; 2011 Nov; 60(Pt 11):1697-1700. PubMed ID: 21737541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.
    Matthews RC; Burnie JP; Tabaqchali S
    J Clin Pathol; 1986 Dec; 39(12):1306-12. PubMed ID: 3100581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
    Meitert T; Meitert E; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa.
    Sokol PA; Woods DE
    Infect Immun; 1986 Mar; 51(3):896-900. PubMed ID: 3081447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas urinary tract infection in patients with spinal cord injury.
    Montgomerie JZ; Guerra DA; Schick DG; Gilmore DS; Tabatabai MF; Morrow JW
    J Am Paraplegia Soc; 1989; 12(1):8-10. PubMed ID: 2513376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriostatic activities in normal human serum against serologically classified Pseudomonas as aeruginosa from the urinary tract infection.
    Fujimura N; Yokoyama R
    Tokushima J Exp Med; 1978 Dec; 25(3-4):87-90. PubMed ID: 111374
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J; Fisher A; Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.
    Freihorst J; Merrick JM; Ogra PL
    Infect Immun; 1989 Jan; 57(1):235-8. PubMed ID: 2491837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for detection and localization of urinary infection. The fluorescence antibody test.
    Pujol A; Linares F; Muñoz J; Rusconi A; Orejas V; Serrallach N; Acomar P
    Urol Int; 1976; 31(6):501-7. PubMed ID: 827041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity.
    Sabharwal N; Chhibber S; Harjai K
    Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.